The study found that cervical cancer may be caused by an imbalance of vaginal bacteria

Share This Post

Almost all cervical cancers are caused by human papillomavirus (HPV), which is called the “common cold” of sexually transmitted infections, because almost everyone with an active life personality will be infected with it. Fortunately, the immune system defeats most human papillomavirus infections, and only a small percentage of people progress to pre-cancer, eventually becoming cancer. But why can some people clear the infection if others can’t resist it?   

To answer this question, Dr. Melissa M.Herbst-Kralovetz of the University of Arizona Cancer Center, an associate professor at the Phoenix Medical School at Union University, studied 100 premenopausal women and found a link between vaginal bacteria and cervical cancer. Compared with cervical cancer and precancerous patients, women with no cervical abnormalities have different vaginal bacterial communities. This difference reveals the direct relationship between “good” bacteria and cervical health. “Bad” bacteria increase the risk of cancer.

The microbial community here is a bacterial community parasitic in the human body. For example, lactic acid bacteria are related to probiotics in yogurt, but unlike probiotics in yogurt, some bacteria found here can promote the health of the vaginal environment. For example, previous research has shown that women with vaginal microbes predominantly gaseous Lactobacillus are more likely to clear HPV infection. Good bacteria can also keep their territory and prevent bad bacteria from entering. However, sometimes they will lose this battle for land.                           

In cervical cancer and precancerous patients, lactic acid bacteria-a beneficial bacteria-are replaced by a mixture of harmful bacteria. In the study, as the number of lactic acid bacteria decreased, cervical abnormalities became more serious. On the other hand, harmful bacteria called Sneathia are associated with pre-cancer, HPV infection and cervical cancer.

Sneathia are rod-shaped bacteria that can grow into fiber chains. They are related to other gynecological diseases, including bacterial vaginosis, miscarriage, premature delivery, HPV infection and cervical cancer. Dr. Herbst-Kralovetz ‘s research found for the first time that a large number of Sneathia populations are associated with all stages of the HPV-to-cancer continuum, from the initial HPV infection to precancerous lesions to invasive cervical cancer.

It is unclear whether Sneathia will actively promote the formation of HPV infections or cancers, or whether they are just for fun. The current study only provides snapshots of women over time. In order to establish causality, future research must be carried out over time.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma
CAR T-Cell therapy

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma

Chimeric antigen receptor (CAR) T-cells that specifically target Fibroblast Growth Factor Receptor 4 (FGFR4), a surface tyrosine receptor that is extensively expressed in rhabdomyosarcoma (RMS), are now undergoing clinical research. However, the effectiveness of these CAR T-cells may be hindered by tumor heterogeneity and inadequate activation. In this study, we present a method to enhance the co-stimulatory and targeting characteristics of a FGFR4 CAR through an optimization process. We substituted the hinge and transmembrane domain of CD8 as well as the 4-1BB co-stimulatory domain with the corresponding domains of CD28. The CARs produced exhibit heightened anti-tumor efficacy in multiple RMS xenograft models, with the exception of the RMS559 cell line, which is known for its aggressive nature.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy